Swiss Medical Regulatory
International Coalition of Medicines Regulatory Authorities (ICMRA)
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, executive-level entity focused on strategic coordination, advocacy, and leadership among regulatory authorities. Its mission is to provide a global architecture that supports enhanced communication, information sharing, and crisis response, while also addressing regulatory science issues. ICMRA aims to tackle current and emerging human medicine regulatory and safety challenges on a global scale. The organization is designed to facilitate collaboration and streamline responses to critical issues within the field of medicine regulation. The website itself was designed by Swissmedic and is maintained by the Pharmaceuticals and Medical Devices Agency, indicating a collaborative effort in its operational infrastructure.
About
**Who they are**
Swiss Medical Regulatory is an entity involved in the International Coalition of Medicines Regulatory Authorities (ICMRA), an organization focused on enhancing global communication, information sharing, and crisis response for medicines among regulatory authorities. The website content indicates that ICMRA's website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
**Expertise & scope**
* Facilitates global communication and information sharing among medicines regulatory authorities.
* Supports crisis response efforts related to medicines.
* Addresses regulatory science issues.
* Engages in strategic efforts to manage current and emerging human medicine regulatory and safety challenges globally.
**Reputation / proof points**
* The ICMRA Chair is Professor Anthony (Tony) Lawler, who began his mandate on 23 October 2025. He also heads the Therapeutic Goods Administration (TGA) in Australia.
* The organization has a history of meetings and summits, including events in Kyoto (2017), Basel (2018), Washington (2018), and San Diego (2019).
Swiss Medical Regulatory is an entity involved in the International Coalition of Medicines Regulatory Authorities (ICMRA), an organization focused on enhancing global communication, information sharing, and crisis response for medicines among regulatory authorities. The website content indicates that ICMRA's website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
**Expertise & scope**
* Facilitates global communication and information sharing among medicines regulatory authorities.
* Supports crisis response efforts related to medicines.
* Addresses regulatory science issues.
* Engages in strategic efforts to manage current and emerging human medicine regulatory and safety challenges globally.
**Reputation / proof points**
* The ICMRA Chair is Professor Anthony (Tony) Lawler, who began his mandate on 23 October 2025. He also heads the Therapeutic Goods Administration (TGA) in Australia.
* The organization has a history of meetings and summits, including events in Kyoto (2017), Basel (2018), Washington (2018), and San Diego (2019).
Additional information
The International Coalition of Medicines Regulatory Authorities (ICMRA) serves as a strategic coordinating entity for regulatory authorities worldwide. Its primary functions include enhancing global communication, facilitating information exchange, and coordinating crisis response for medicines. The organization's website design and maintenance involve Swissmedic and the Pharmaceuticals and Medical Devices Agency, suggesting a connection to Swiss regulatory infrastructure. ICMRA addresses a range of regulatory science issues and global safety challenges within the human medicines sector.
Key Highlights
-
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities.
Source
“The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities”
-
ICMRA enhances global communication, information sharing, and crisis response for medicines.
Source
“enhancing global communication, information sharing, and crisis response for medicines.”
-
The ICMRA Secretariat can be contacted via email.
Source
“ICMRA Secretariat can be contacted at ICMRASecretariat@health.gov.au.”
-
The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Source
“Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency”
-
Professor Anthony (Tony) Lawler serves as the ICMRA Chair, beginning his mandate on 23 October 2025.
Source
“The Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) is Professor Anthony (Tony) Lawler. He began his mandate as ICMRA Chair on 23 October 2025.”
Certifications & Trust Signals
-
ICMRA engages in strategic initiatives to address global regulatory and safety challenges for medicines.
Source
“address current and emerging human medicine regulatory and safety challenges globally, strategically”
-
The organization has a history of international meetings and summits.
Source
“2017 ICMRA Kyoto 2018 ICMRA Basel 2018 ICMRA Summit Washington 2019 ICMRA San Diego”
Buyer Snapshot
Best for
- Organizations seeking to understand global regulatory coordination for medicines.
- Entities involved in international medicine regulation and safety.
How engagement typically works
- Information sharing and strategic coordination.
- Global communication facilitation.
Typical deliverables
- Insights into international regulatory best practices.
- Information on global medicine safety initiatives.
Good to know
- Best when seeking high-level coordination and information exchange among regulatory bodies.
HQ:
Geneva, Switzerland
Languages:
English, German, French
Timezones:
Europe/Zurich
Claim status:
Listed
Services & Capabilities
Best CH-REP (Swiss Authorized Rep) | Compare & Get Quotes
Jurisdictions:
CH
Countries:
CH
Industries:
Medical devices, IVD
Portfolio:
6-25
Onboarding time:
3–10 days
Pricing model:
Custom pricing
Starting from:
CHF 2,100
Included services:
Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability
Swiss Local Contact:
No
Labeling Support:
No
Can Be Named On Label:
No
Vigilance Contact Support:
No
Swiss Entity Canton Or Region:
CH
Additional ch_rep Details
Supports MDR
true
Supports IVDR
true
Swiss Entity Canton Or Region
CH
Labeling Support
true
Swiss Local Contact
true
Vigilance Contact Support
true
Can Be Named On Label
true
⚡ Instant booking available
Appoint a Swiss Authorized Representative (CH-REP) for Medical Devices
Compare Swiss Medical Regulatory and other vetted providers — instant pricing, no RFQ needed.
